SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.

Immunocompromised patient Intra-host evolution Prolonged infection SARS-CoV-2 Sequencing

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 01 04 2022
revised: 09 06 2022
accepted: 14 06 2022
pubmed: 21 6 2022
medline: 9 9 2022
entrez: 20 6 2022
Statut: ppublish

Résumé

Intra-host SARS-CoV-2 evolution during chronic infection in immunocompromised hosts has been suggested as being the possible trigger of the emergence of new variants. Using a deep sequencing approach, we investigated the SARS-CoV-2 intra-host genetic evolution in a patient with HIV over a period of 109 days. Sequencing of nasopharyngeal swabs at three time points demonstrated dynamic changes in the viral population, with the emergence of 26 amino acid mutations and two deletions, 57% of them in the Spike protein. Such a combination of mutations has never been observed in other SARS-CoV-2 lineages detected so far. Our data confirm that persistent infection in certain immunocompromised individuals for a long time may favor the dangerous emergence of new SARS-CoV-2 variants with immune evasion properties.

Identifiants

pubmed: 35724829
pii: S1201-9712(22)00359-9
doi: 10.1016/j.ijid.2022.06.023
pmc: PMC9212919
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-448

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Références

Science. 2021 Aug 6;373(6555):648-654
pubmed: 34210893
Genomics Proteomics Bioinformatics. 2022 Feb;20(1):60-69
pubmed: 35033679
Biochem Biophys Res Commun. 2021 Jan 1;534:374-380
pubmed: 33272568
Nat Commun. 2021 Nov 4;12(1):6405
pubmed: 34737266
Comput Struct Biotechnol J. 2021 Oct 4;:
pubmed: 34630935
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Sci Rep. 2021 Oct 12;11(1):20274
pubmed: 34642465
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Int J Infect Dis. 2022 Jan;114:178-182
pubmed: 34757008
Pediatr Blood Cancer. 2021 Dec;68(12):e29277
pubmed: 34453477
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750

Auteurs

Erika Giorgia Quaranta (EG)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy. Electronic address: equaranta@izsvenezie.it.

Alice Fusaro (A)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Edoardo Giussani (E)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Valeria D'Amico (V)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Maria Varotto (M)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Matteo Pagliari (M)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Maria Teresa Giordani (MT)

Infectious Diseases Unit, Alto Vicentino Hospital, ULSS 7 Pedemontana, Santorso, Vicenza, Italy.

Maira Zoppelletto (M)

San Bassiano Hospital, ULSS 7 Pedemontana, Bassano del Grappa, Vicenza, Italy.

Francesca Merola (F)

San Bassiano Hospital, ULSS 7 Pedemontana, Bassano del Grappa, Vicenza, Italy.

Antonio Antico (A)

San Bassiano Hospital, ULSS 7 Pedemontana, Bassano del Grappa, Vicenza, Italy.

Paola Stefanelli (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, Roma, Italy.

Calogero Terregino (C)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Isabella Monne (I)

Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH